An International Reputation for Cardiac Excellence
Stanford is recognized worldwide as a pioneering center for heart
transplants. Dr. Norman Shumway and his colleagues developed the
experimental basis for transplants in their early work, which then
paved the way for the first adult heart transplant in the U.S. at
Stanford in 1968. To date, our medical teams have performed more than
1,200 heart transplants.
Our multidisciplinary program includes:
Specialists in heart failure management and heart
Experts in cardiothoracic surgery
State-of-the-art diagnostic tests from radiologists, molecular
biologists and pathologists
Access to new clinical trials
in heart failure and heart transplantation
Innovations introduced in the transplant field from Stanford include:
The operative method for heart transplantation
use of percutaneous, transvenous biopsy of the heart to detect
The use of new immunosuppressive drugs, including
cyclosporine, to prevent rejection
The first successful
heart-lung transplantation procedure
The use of peripheral
blood gene expression testing to identify patients at low risk for
rejection, allowing doctors to safely decrease the number of
Approximately 40 to 50 patients undergo heart transplantation each
year at Stanford. The procedures are performed in patients from
newborns to adults over 60 years of age. Almost every type of
end-stage heart disease has been treated here, and the Stanford team
remains a leader in introducing new concepts and treatments to improve
outcomes for transplant patients.
This unusual procedure, known as a "domino" transplant, occurs when one recipient receives a heart-lung transplant from a deceased donor, while the existing healthy heart of the heart-lung recipient is given to a second patient. The rare procedure has only been performed eight times at Stanford, last in 1994.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.